
Olympus adds EndoRobotics tools to endoscopy portfolio
Olympus will exclusively distribute EndoRobotics’ robot-assisted technologies globally as part of its EndoTherapy portfolio, beginning with the U.S.
Section
M&A, vendor news, reimbursement, and the economics of imaging.

Olympus will exclusively distribute EndoRobotics’ robot-assisted technologies globally as part of its EndoTherapy portfolio, beginning with the U.S.

Olympus and Canon Medical Systems USA launched the Aplio i800 EUS premium ultrasound system for gastroenterology and pulmonary endoscopic use in the U.S.

Eden Radioisotopes has filed a construction permit application with the NRC for a New Mexico isotope production complex.

Dicom Systems said Moffitt Cancer Center will use its Unifier Platform to support and scale digital pathology workflows. The platform is designed to standardize pathology image and data exchange across systems.

Radiology Partners appointed former Maryland Gov. Larry Hogan to its board of directors. The company said Hogan brings public health, healthcare policy, and cancer advocacy experience to the role.

Rad AI named David Leonard chief operating officer and Elizabeth Bergey, MD, its first chief clinical officer. The appointments come as the company scales its radiology reporting and workflow products.

RadNet formed a joint venture with Trinity Health’s Saint Alphonsus Health System through a majority stake in Intermountain Medical Imaging. The deal adds 5 Boise-area imaging centers and expands RadNet into Idaho.

Illuminant Surgical raised $8.4M in seed funding to support Skylight, an image-based guidance platform that projects internal anatomy from medical images onto the patient’s body during procedures.

PharmaLogic opened a PET radiopharmaceutical manufacturing facility in Atlanta to expand production and distribution across the Southeast. The site is part of a $250M U.S. infrastructure investment.

Echosens appointed Romain Baujard as group CEO, effective May 1. He succeeds Dominique Legros, who will retire after leading the company since 2019.

AIIMS New Delhi has begun routine clinical use of Hyperfine’s Swoop portable MRI system. The deployment marks India’s first bedside MRI system for routine clinical brain imaging.

C-Ray Therapeutics received FDA active status for its Type II Drug Master File for copper-64 chloride. The filing can now be referenced by radiopharmaceutical developers in IND and NDA submissions.

Azra AI has acquired Thynk Health, a lung cancer screening and incidental findings management company. The combined platform will support imaging-driven care coordination from detection through diagnosis, treatment, and survivorship.

Aidoc said the round was led by Growth Equity at Goldman Sachs Alternatives and brings its total funding to more than $500M. The company plans to expand its CARE foundation model, aiOS enterprise platform, and automated imaging-report capabilities.

Plus Therapeutics began manufacturing activities and technology transfer with SpectronRx to support late-stage clinical supply of Reyobiq, its rhenium-186 radiopharmaceutical candidate for CNS cancers.